Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01280994 · ClinicalTrials.gov registry record · Phase 2
Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
A Phase 2 study of Interstitial Lung Disease, sponsored by Bastiaan Driehuys.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 445
- Enrollment target
- 1
- Study location
NCT01280994 is a Phase 2 study of Interstitial Lung Disease that is actively recruiting participants, run by Bastiaan Driehuys. The registered enrollment target is 445 participants, below the 554-participant average among 36 other Interstitial Lung Disease trials with a reported enrollment target (20% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01280994, a Phase 2 study of Interstitial Lung Disease, is actively recruiting participants, sponsored by Bastiaan Driehuys.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 445 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop and evaluate the usefulness of MRI using 129Xe gas for regional assessment of pulmonary function. Specifically, three forms of 129Xe MRI contrast will be the investigators focus - 1) imaging of the 129Xe ventilation distribution, 2) imaging the alveolar microstructure via the 129Xe apparent diffusion coefficient (ADC), and 3) imaging 129Xe that dissolves in the pulmonary blood and tissues upon inhalation. Such imaging of 129Xe gas transfer is expected to be uniquely sensitive to pathologies affecting gas exchange (fibrosis, emphysema, pulmonary hypertension) and provide new insights regarding the normal resting heterogeneity of pulmonary gas exchange.
Conditions Studied
Interventions
- DRUG Hyperpolarized 129Xenon Gas
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 445 participants |
| Start Date | 2011-01 |
| Est. Completion | 2030-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01280994
The ClinicalTrials.gov registry entry for NCT01280994 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 445 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 554-participant average among 36 other Interstitial Lung Disease trials with a reported enrollment target (20% lower). The listed sponsor is Bastiaan Driehuys, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Interstitial Lung Disease appearing as the primary indexed condition, and to 1 intervention - of which Hyperpolarized 129Xenon Gas is the first listed.
NCT01280994 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT01280994 about?
NCT01280994 is a clinical study titled "Hyperpolarized 129Xe MRI for Imaging Pulmonary Function". The purpose of this study is to develop and evaluate the usefulness of MRI using 129Xe gas for regional assessment of pulmonary function. Specifically, three forms of 129Xe MRI contrast will be the investigators focus - 1) imaging of the 129Xe ventilation distribution, 2) imaging the alveolar micros...
What is the current status of trial NCT01280994?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 445 participants. The study started on 2011-01. Estimated completion is 2030-12.
What conditions does trial NCT01280994 study?
This clinical trial studies the following conditions: Interstitial Lung Disease.
What interventions are being tested in trial NCT01280994?
The interventions under investigation include: Hyperpolarized 129Xenon Gas (DRUG).
Who is sponsoring clinical trial NCT01280994?
This trial is sponsored by Bastiaan Driehuys, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01280994 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Interstitial Lung Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
RECRUITING · Phase 2
-
Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
RECRUITING · Phase 2
-
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
RECRUITING · Phase 2
-
129Xe MRI Cardiopulmonary
RECRUITING · Phase 2
-
Pulmonary Hypertension SOLAR
RECRUITING · Phase 2
-
H01 in Adults With Interstitial Lung Disease (The SOLIS Study)
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.